Issue 2, 2014

Ligation of anti-cancer drugs to self-assembling ultrashort peptides by click chemistry for localized therapy

Abstract

Self-assembling ultrashort peptides from aliphatic amino acids were functionalized with platinum anti-cancer drugs by click chemistry. Oxaliplatin-derived hybrid peptide hydrogels with up to 40% drug loading were tested for localized breast cancer therapy. Stably injected gels showed significant tumor growth inhibition in mice and a better tolerance compared to the free platinum drug.

Graphical abstract: Ligation of anti-cancer drugs to self-assembling ultrashort peptides by click chemistry for localized therapy

Supplementary files

Article information

Article type
Edge Article
Submitted
10 Jul 2013
Accepted
17 Oct 2013
First published
18 Oct 2013

Chem. Sci., 2014,5, 625-630

Ligation of anti-cancer drugs to self-assembling ultrashort peptides by click chemistry for localized therapy

M. R. Reithofer, K. Chan, A. Lakshmanan, D. H. Lam, A. Mishra, B. Gopalan, M. Joshi, S. Wang and C. A. E. Hauser, Chem. Sci., 2014, 5, 625 DOI: 10.1039/C3SC51930A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements